BIOPHTA Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$7.03M
- Investors
-
13
BIOPHTA General Information
Description
Developer of ophthalmic pharmaceutical treatments designed to improve the efficacy of retinal disease therapies and reduce reliance on eye drops and intraocular injections. The company offers once-weekly, non-invasive topical treatments, including a glaucoma therapy and an anti-vascular endothelial growth factor treatment for diabetic retinopathy, enabling patients and healthcare providers to manage retinal and other eye conditions through less invasive treatment options.
Contact Information
Website
www.biophta.comCorporate Office
- Le Biopôle
- 6, rue Pierre Joseph Colin
- 35000 Rennes
- France
Corporate Office
- Le Biopôle
- 6, rue Pierre Joseph Colin
- 35000 Rennes
- France
BIOPHTA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Seed Round | 01-Jun-2024 | $7.03M | Completed | Generating Revenue | ||
| 8. Accelerator/Incubator | 12-May-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 28-May-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 18-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 02-Jun-2020 | $54.6K | $54.6K | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 16-Mar-2020 | Completed | Pre-Clinical Trials |
BIOPHTA Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| AP Seed 2 | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BIOPHTA Comparisons
Industry
Financing
Details
BIOPHTA Competitors (2)
One of BIOPHTA’s 2 competitors is Novaliq, a Venture Capital-Backed company based in Heidelberg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novaliq | Venture Capital-Backed | Heidelberg, Germany | ||||
| Oculis Holding | Formerly VC-backed | Zug, Switzerland |
BIOPHTA Patents
BIOPHTA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022323447-A1 | Mucoadhesive ocular delivery system for the treatment of glaucoma | Pending | 03-Aug-2021 | ||
| CA-3227607-A1 | Mucoadhesive ocular delivery system for the treatment of glaucoma | Pending | 03-Aug-2021 | ||
| EP-4380545-A1 | Mucoadhesive ocular delivery system for the treatment of glaucoma | Pending | 03-Aug-2021 | ||
| US-20240335375-A1 | Mucoadhesive ocular delivery system for the treatment of glaucoma | Pending | 03-Aug-2021 | ||
| WO-2023012239-A1 | Mucoadhesive ocular delivery system for the treatment of glaucoma | Inactive | 03-Aug-2021 | A61K9/0048 |
BIOPHTA Signals
BIOPHTA Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elaia Partners | Venture Capital | Minority | ||
| GO Capital | Venture Capital | Minority | ||
| HTL Biotechnology | PE-Backed Company | Minority | ||
| Merieux Equity Partners (Lyon) | PE/Buyout | Minority | ||
| UI Investissement | PE/Buyout | Minority |
BIOPHTA FAQs
-
When was BIOPHTA founded?
BIOPHTA was founded in 2020.
-
Where is BIOPHTA headquartered?
BIOPHTA is headquartered in Rennes, France.
-
What is the size of BIOPHTA?
BIOPHTA has 7 total employees.
-
What industry is BIOPHTA in?
BIOPHTA’s primary industry is Drug Delivery.
-
Is BIOPHTA a private or public company?
BIOPHTA is a Private company.
-
What is the current valuation of BIOPHTA?
The current valuation of BIOPHTA is .
-
What is BIOPHTA’s current revenue?
The current revenue for BIOPHTA is .
-
How much funding has BIOPHTA raised over time?
BIOPHTA has raised $8.4M.
-
Who are BIOPHTA’s investors?
Elaia Partners, GO Capital, HTL Biotechnology, Merieux Equity Partners (Lyon), and UI Investissement are 5 of 13 investors who have invested in BIOPHTA.
-
Who are BIOPHTA’s competitors?
Novaliq and Oculis Holding are competitors of BIOPHTA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process